Penn Medicine Provider
Gastroenterology
Christopher J. Schmoyer, MD
4.9
(232)
Accepting new patients
Sees patients age 18 and up
Penn Digestive and Liver Health Center University City

About me

  • Assistant Professor of Clinical Medicine (Gastroenterology)

Education and training

  • Medical School: Geisinger Commonwealth School of Medicine
  • Residency: Virginia Commonwealth University
  • Fellowship: Thomas Jefferson University Hospital

What my patients think about me

Average Rating
4.9

232 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
dr schmoyer was really interested in making me feel better and living a better life which is a huge relief
May 2025
5.0
5.0
dr. schmoyer is an excellent physician. he's caring, and extremely knowledgeable about my condition. he answers all questions and i never feel like he's rushing me. i would definitely recommend him a thousand times over.
May 2025
5.0
5.0
good care.
May 2025
5.0
5.0
he's excellent and it's always great to see him.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Schmoyer is a Penn Medicine physician.

Qualifications and experience

My research

Bickford, David; Schmoyer, Christopher; Tse, Chung Sang Duodenal-Acquired Intestinal Lymphangiectasia After Lymph Node Excision and Inferior Vena Cava Injury in an 18-Year-Old Woman , ACG Case Reports, 12(2): 2025


Schmoyer CJ, Sun K, Zack J, Kumar P, Shivashankar R. Adverse Events and Compliance Among Inflammatory Bowel Disease Patients Treated With Home- vs Office-Based Biologic Infusions , Inflamm Bowel Dis, 30(9): 2024,1529-35


Kang H, Schmoyer CJ, Weiss A, Lewis JD. Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease , Inflamm Bowel Dis: 2024


Scott Manski, Christopher J. Schmoyer, Alice Pang, Joshua Lieberman, Micaela Gernhardt, Elizabeth Conn, Neveda Murugesan, Alexandra Leto, Ryan Erwin, Taylor Kavanagh, Mitchell Conn The Safety of the Re-Opening of an Academic Medical Center Outpatient Endoscopy Unit During the COVID-19 Pandemic , Gastroenterology Research, 15(4): 2022,200-206


Schmoyer CJ, Sun K, Zack J, Shivashankar R Outcomes of Inflammatory Bowel Disease Patients Treated with Home- versus Office-Based Biologic Infusions , Digestive Disease Week, San Diego CA: 2022


Garrido D, Habig G, Schmoyer C, Katz L Hematemesis from a Large Gastric AVM: An Uncommon Presentation of HHT , American College of Gastroenterology, 116(3): 2021,S968


Schmoyer CJ, Saidman J, Bohl JL, Bierly CL, Kuemmerle JF, Bickston SJ The Pathogenesis and Clinical Management of Stricturing Crohn Disease , Inflamm Bowel Dis, 27(11): 2021,1839-53


Manski S, Schmoyer CJ, Pang A, Lieberman J, Gernhardt M, Murugesan N, Leto A, Erwin R, Kavanagh TR, Conn M A Safety Assess of the Re-opening of an Academic Medical Center Outpatient Endoscopy Unit during the COVID-19 Pandemic , Thomas Jefferson University Hospital, Philadelphia, PA, 160(6): 2021,S427


Manski S, Schmoyer CJ, Pang A, Lieberman J, Gernhardt M, Murugesan N, Leto A, Erwin R, Kavanagh TR, Conn M A Safety Assess of the Re-opening of an Academic Medical Center Outpatient Endoscopy Unit during the COVID-19 Pandemic , Digestive Disease Week, Virtual Conference, 160(6): 2021,S427


Schmoyer CJ, Sterling RK. Reply , Clin Gastroenterol Hepatol, 19(4): 2021,897